Global Stem Cells Market report published by Accurize Market Research forecast that the global market is expected to reach $15 billion by 2025; growing at a CAGR of 14.8% from 2017 to 2025. By geography, the Asia Pacific and North America are expected to grow at a CAGR of XX% and XX%, respectively, during the forecast period.

Request Sample: https://www.accurizemarketresearch.com/report/global-stem-cells-market/sample-request

Increase in the number of clinical trials for testing future treatment possibilities of cord blood, rising awareness about the life-saving power of umbilical cord blood stem cells to drive the global market

Increase in the number of clinical trials for testing future treatment possibilities of cord blood, rising awareness about the life-saving power of umbilical cord blood stem cells fuels the growth of the global stem cells market. Moreover, an increase in the patient population, upsurge in the approval for clinical trials in stem cell exploration might also provide growth opportunities.

Market Segmentation

The global stem cells market is split into application and geography. Application is segmented into regenerative medicine and current stem cell therapy applications. North America, Europe, Asia-Pacific and Rest of the world (RoW) are the geographical segments of the market.

Request Customization: https://www.accurizemarketresearch.com/report/global-stem-cells-market/ask-for-customization

Top players in the market

Major companies operating in the market include Astellas Pharma, Athersys, Cytori, Therapeutics Inc., Fate Therapeutics Inc., Geron Corporation, Osiris Therapeutics Inc., Pluristem Therapeutics Inc., Thermo Fisher Scientific, Vericel Corporation and ViaCyteInc. among others.